SCHEMBL6427259

SCHEMBL6427259

NC(=O)c1cccc(CN2C(=O)C(Cl)=C(c3ccc(Cl)cc3)C2=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.49
KMT2A Q03164 2/20 0.45
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
PRKAG1 P54619 3/20 0.44
PRKAB1 Q9Y478 3/20 0.44
PRKAA2 P54646 2/20 0.44
PARP1 P09874 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
BRD4 O60885 1/20 0.41
PRKAA1 Q13131 1/20 0.41
MAPT P10636 2/20 0.40
NR4A2 P43354 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE7A Q13946 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430925 0.85 PRKAG1 (0.46) KMT2ANR1H2NR1H3PRKAG1PRKAB1
SCHEMBL6427927 0.83 MAPT (0.52) KMT2ANR1H2NR1H3MAPTKDM4E
SCHEMBL6428843 0.79 NR1H2 (0.52) ADRA1DKMT2ANR1H2NR1H3MAPT
SCHEMBL6426743 0.77 CMA1 (0.57) ADRA1DKMT2ANR1H2NR1H3MAPT
SCHEMBL6428883 0.76 NR1H2 (0.48) KMT2ANR1H2NR1H3MAPTKDM4E
SCHEMBL6427708 0.76 NR1H2 (0.50) KMT2ANR1H2NR1H3MAPTKDM4E
SCHEMBL6426484 0.76 APAF1 (0.52) KMT2ANR1H2NR1H3MAPTPOLB
SCHEMBL6427000 0.75 NR1H2 (0.60) KMT2ANR1H2NR1H3MAPTKDM4E
SCHEMBL6426845 0.72 MAPT (0.50) KMT2ANR1H2NR1H3MAPTMAPK1
SCHEMBL6427394 0.70 NR1H2 (0.51) NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed